Daniel Spiegelman
2015
In 2015, Daniel Spiegelman earned a total compensation of $3.9M as Executive Vice President, Chief Financial Officer at BioMarin Pharmaceutical, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $362,546 |
|---|---|
| Option Awards | $1,259,291 |
| Salary | $505,192 |
| Stock Awards | $1,712,088 |
| Other | $22,941 |
| Total | $3,862,058 |
Spiegelman received $1.7M in stock awards, accounting for 44% of the total pay in 2015.
Spiegelman also received $362.5K in non-equity incentive plan, $1.3M in option awards, $505.2K in salary and $22.9K in other compensation.
Rankings
In 2015, Daniel Spiegelman's compensation ranked 2,279th out of 13,638 executives tracked by ExecPay. In other words, Spiegelman earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,279 out of 13,638 | 83rd |
Division Manufacturing | 819 out of 5,187 | 84th |
Major group Chemicals And Allied Products | 292 out of 1,857 | 84th |
Industry group Drugs | 231 out of 1,531 | 85th |
Industry Pharmaceutical Preparations | 182 out of 1,179 | 85th |
Source: SEC filing on April 25, 2017.
Spiegelman's colleagues
We found four more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2015.
2015
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2015
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2015
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2015
Jeff Ajer
BioMarin Pharmaceutical